Looks like you’re on the UK site. Choose another location to see content specific to your location
UK patients ‘confused by information they receive on medicines’
Many UK patients are finding it difficult to make use of the information available to them to judge the benefits and risks of essential medicines.
A study conducted by the Academy of Medical Sciences has indicated that only 37 percent of the public trust evidence from medical research, compared to 65 percent who would put faith in the experiences of friends and family.
One key sticking point is the quality of patient information leaflets provided with medicines, as it was deemed that these documents focus too much on detailing possible side effects, rather than explaining potential benefits. This can make it more difficult for patients to make informed decisions about medicines.
As such, the report called for European lawmakers to work with national regulatory authorities, pharmaceutical companies and patients to reform these leaflets to give a clearer and more balanced summary of potential pros and cons.
It also outlined a number of suggested questions for patients to ask during medical appointments, while calling for the NHS Choices website to be developed as a go-to source of trusted online information.
Report chair Professor Sir John Tooke said: "With our ageing population and ever more sophisticated treatments being made available, we need to act now to give patients clearer and more useful information about the medicines they take."
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard